Hims & Hers Health (HIMS) Cost of Revenue (2020 - 2026)

Hims & Hers Health has disclosed Cost of Revenue across 7 years of filings, most recently posting $222.0 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $222.0 million, down 3.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $910.1 million (up 5.7% YoY), and the FY2025 annual result was $919.3 million, up 35.42% from the prior year.
• Cost of Revenue came in at $222.0 million for Q1 2026 at Hims & Hers Health, down from $238.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $487.1 million in Q4 2024 to a low of $26.4 million in Q2 2022.
• The 5-year median for Cost of Revenue is $83.7 million (2024), against an average of $147.6 million.
• Across the five-year window, Cost of Revenue slumped 61.74% in 2022 and surged 852.06% in 2023, its largest moves.
• Hims & Hers Health's Cost of Revenue stood at $34.9 million in 2022, then soared by 852.06% to $331.9 million in 2023, then surged by 46.73% to $487.1 million in 2024, then slumped by 51.13% to $238.0 million in 2025, then dropped by 6.74% to $222.0 million in 2026.
• The last three Cost of Revenue figures came in at $222.0 million (Q1 2026), $238.0 million (Q4 2025), and $232.2 million (Q3 2025), per Business Quant data.